Ranbaxy's new drug to hit US in Jan
Ranbaxy Laboratories, the country's largest drugmaker, said it would launch a generic version of GlaxoSmithKline;s blockbluster antibiotic Augmentin in the United States next
Ranbaxy Laboratories, the country's largest drugmaker, said it would launch a generic version of GlaxoSmithKline;s blockbluster antibiotic Augmentin in the United States next